liquidation

door exit shut close end walk away
Biotech

Alis wants to free capital 'trapped' at struggling biotechs

Alis is proposing to buy biotechs and return most of their cash to shareholders, offering them an alternative to exits such as reverse mergers.
Nick Paul Taylor Apr 18, 2025 9:45am
brain art

Struggling Relmada pays $3M for Tourette's asset from Asarina

Feb 7, 2025 11:00am
end of the road road block shut down closed blocked

Asarina to close after efforts to partner Tourette's drug fail

Jul 24, 2024 10:32am
sale for sale sell

SQZ opts for liquidation, $11.8M asset fire sale to Stemcell

Mar 1, 2024 10:20am
unravel break rope tie fray fall apart thread string

The unraveling of EQRx's low-cost drug dream

Oct 5, 2023 10:47am
footprints light snow winter

Fresh Tracks to dissolve after hunt for buyer comes up empty

Sep 19, 2023 5:37pm